CINECA IRIS Institutional Research Information System

CERUTI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.617
EU - Europa 4.804
AS - Asia 2.860
SA - Sud America 115
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 14.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.576
CN - Cina 1.025
IT - Italia 809
SG - Singapore 780
IE - Irlanda 728
DE - Germania 727
SE - Svezia 589
FI - Finlandia 464
KR - Corea 422
UA - Ucraina 407
JP - Giappone 299
FR - Francia 292
VN - Vietnam 209
GB - Regno Unito 183
PL - Polonia 179
AT - Austria 151
DK - Danimarca 120
BR - Brasile 101
IN - India 54
RU - Federazione Russa 45
NL - Olanda 36
CA - Canada 34
BE - Belgio 25
SN - Senegal 24
EU - Europa 13
ID - Indonesia 12
UZ - Uzbekistan 12
IR - Iran 11
HK - Hong Kong 9
GR - Grecia 8
AU - Australia 7
CZ - Repubblica Ceca 7
ES - Italia 7
MX - Messico 6
TR - Turchia 5
AR - Argentina 4
EC - Ecuador 4
HU - Ungheria 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
DZ - Algeria 3
JO - Giordania 3
MA - Marocco 3
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
BY - Bielorussia 2
CH - Svizzera 2
KE - Kenya 2
MU - Mauritius 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
TW - Taiwan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 14.460
Salva come PNG Salva come JPEG
Città #
Chandler 747
Beijing 744
Ann Arbor 730
Dublin 726
Santa Clara 509
Jacksonville 422
Singapore 348
Dearborn 300
Princeton 234
Columbus 200
Houston 183
Boston 181
Ashburn 180
Dong Ket 177
Warsaw 174
Wilmington 171
Villeurbanne 156
Fairfield 151
Vienna 150
Medford 146
Torino 127
Frankfurt am Main 119
Woodbridge 115
Nyköping 95
Munich 81
Fremont 74
Boardman 67
Milan 65
Seattle 65
Cambridge 54
Pisa 45
New York 34
Hefei 32
Falls Church 31
Guangzhou 30
Rome 30
Norwalk 28
Helsinki 26
Kunming 26
Verona 24
Redwood City 23
Brussels 21
Nanjing 21
Washington 17
Düsseldorf 15
Moscow 15
Nanchang 15
Buffalo 14
Cimitile 14
Toronto 14
Falkenstein 13
Hebei 12
San Mateo 12
Hangzhou 11
Jakarta 11
Phoenix 11
Pune 11
Zhengzhou 11
Harbin 9
Nuremberg 9
Chongqing 8
Hong Kong 8
Mumbai 8
Palermo 8
Shanghai 8
Wuhan 8
Bari 7
Fuzhou 7
Gwangjin-gu 7
Lachine 7
San Diego 7
Tulsa 7
Hanover 6
Jinan 6
Los Angeles 6
Paderno Dugnano 6
Shenyang 6
Dallas 5
London 5
Loreto 5
Mountain View 5
Napoli 5
Ottawa 5
Rio de Janeiro 5
Shenzhen 5
Turin 5
Ardabil 4
Aversa 4
Brescia 4
Changsha 4
Lavagna 4
Leawood 4
Matsuyama 4
Monmouth Junction 4
Philadelphia 4
Recife 4
Redmond 4
Ruda Śląska 4
São Paulo 4
University Park 4
Totale 8.297
Salva come PNG Salva come JPEG
Nome #
Carbammati lipidici di farmaci antitumorali. 458
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase 223
Farmaci macromolecolari: veicolazione e direzionamento mediante albumina umana 196
Study of (1-alkoxyethyl)diphenylphosphine oxides. I. Syntheses and structural analyses of phenylethoxy, methoxy and isopentyloxy derivatives. 189
Robinia “Georgia da Torino”. 185
1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis[1,2,4]triazolo[4,3-a:3’,4’-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties 177
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 167
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells 161
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase. 159
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 157
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase 149
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver. 148
Comparison of experimental and molecular modelling results on phosphine oxides. 144
A Simple Synthesis and some Chemical Properties of Benzo-1,4-dithiafulvenes 143
Study of (1-alkoxyethyl)diphenylphosphine oxides. II. Conformational analysis by theoretical calculations. 136
Sintesi di inibitori suicidi dello squalene 2,3-epossido ciclasi. 134
Study of (1-alkoxyethyl)diphenylphosphine oxides. IV. Conclusive conformational study by NMR and molecular mechanics calculations. 134
Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy 130
Study of (1-alkoxyethyl)diphenylphosphine oxides. III. Nuclear magnetic resonance analysis. 125
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases 125
[Antiproliferative effect of an extract of Aspergillus terreus] 121
Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as Inhibitors of Liver and Yeast Oxidosqualene Cyclase. 120
Studio del metabolismo in vivo nel ratto dell'antiparkinson Budipina. 112
Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry 111
Structure and reactivity of the dammarenyl cation: configurational transmission in triterpene synthesis 107
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 106
Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique 105
Sintesi di aldeidi per omologazione di composti carbonilici, via 1,4-benzoditiafulveni. 101
An NMR and molecular mechanics study of squalene and squalene derivatives 99
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). 99
Synthesis and biological activity of 22,23-epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide - lanosterol cyclase. 98
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 97
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors 94
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 93
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis. 92
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface 92
2,3-oxidosqualene cyclase and squalene epoxidase: enzymology, mechanism and inhibitors 91
Azasqualeni N-ossidi e bis-azasqualeni, inibitori dell'enzima squalene epossido ciclasi. 91
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 90
2,3-oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 89
N-oxide as a potential function in the design of enzyme inhibitors. Application to 2,3-epoxysqualene-sterol cyclases. 88
The metabolic fate of the anti-parkinsonian drug budipine in rats. 87
2-Aza-2,3-dihydrosqualene: biodistribution and pharmacokinetic properties in mice. 87
New DSPE-PEG-Folate conjugates for liposomal drug targeting 87
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 87
Bis(2-Acyloxy or Aroylxybenzenethiolates)Mercury (II) as Inhibitors of “Fusarium” 86
Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae. 86
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors. 86
A convenient synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 86
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. 85
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 83
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase. 83
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 83
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase. 83
The squalene-2,3-epoxide cyclase as a model for the development of new drugs. 82
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. 82
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 82
2,3-Oxidosqualene cyclase and squalene epoxidase as target enzymes for the development of new sterol biosynthesis inhibitors 82
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase 82
The in vitro metabolism of 1,3-thiazolidine derivatives of theophylline: a study on structure-metabolism correlation. 82
Synthesis of HEI analogues of the C-20 carbocation forming during lanosterol biosynthesis, as hypocholesterolemics. 81
Total synthesis of the hypocholesterolemic and antifungal drug 10-azasqualene 2,3-epoxide, the first non-cyclized analogue of the C-8 carbonium ion formed during squalene epoxide cyclization. 81
22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase. 80
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 80
Azasqualene alcohol and derivatives. New selective inhibitors of 2,3-oxidosqualene cyclase. 80
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 79
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 77
Synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 77
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 77
Synthesis of tritium-labelled 19-azasqualene 2,3-epoxide and derivatives, as probes to study their hypocholesterolemic activity. 76
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase 76
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage. 75
Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives. 74
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study. 74
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase. 74
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 74
Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives. 73
Metabolismo ossidativo di funzioni acetaliche e tioacetaliche cicliche: studio della correlazione struttura metabolismo. 72
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 71
Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase. 71
Studio comparato dell'attività inibitoria di derivati squalenoidi acetilenici ed allenici, nei confronti dell'enzima squalene epossidasi e delle monoossigenasi P-450 dipendenti. 71
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers. 70
An NMR and molecular mechanics study of squalene and squalene derivatives. 70
Studio del metabolismo del 7-(1,3-ditiolan-2-ilmetil)teofillina, un nuovo farmaco ad attività antibroncospastica e mucolitica. 70
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity. 69
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 69
Rational inhibition of sterol biosynthesis: new time-dependent inhibitors of 2,3-oxidosqualene cyclase. 69
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 68
In vitro metabolism of 7-(1,3-thiazolidin-2ylmethyl)theophylline: the metabolic fate of the 1,3-thiazolidine ring. 68
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 67
Stereospecific inhibition of sterol biosynthesis in HEP G2 and Saccharomyces cerevisiae cell cultures by 29-methylidene-oxidosqualene derivatives. 67
2-Aza-2,3-dihydrosqualene and its N-oxide as inhibitors of sterol biosynthesis in bramble cell suspension cultures. 66
Sostanze mutagene e cancerogene in funghi del genere Agaricus. 66
Antifungal spectrum of two acyclic inhibitors of 2,3-oxidosqualene cyclase. 66
Total synthesis and inhibition of sterol biosynthesis by 10-azasqualene 2,3-epoxide, a high-energy intermediate analogue 66
Incorporation of lipophilic gemcitabine prodrugs in liposomes 66
Preparation, characterization, cytotoxicity and pharmacokinetcs of liposomes containing lipophilic gemcitabine prodrugs 65
Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes. 65
Synthesis and inhibition of cholesterol biosynthesis by azasqualene alcohol and derivatives. 65
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives. 64
Totale 10.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.637
article - articoli 0
book - libri 0
conference - conferenze 17.761
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020402 0 0 0 0 0 0 0 0 0 172 143 87
2020/20211.410 182 49 86 70 127 73 117 37 140 96 126 307
2021/20221.901 71 56 66 139 114 65 144 138 60 140 391 517
2022/20232.335 295 133 37 235 212 697 245 122 212 17 97 33
2023/2024893 140 182 54 30 51 92 19 36 3 44 63 179
2024/20251.939 28 107 58 294 834 96 28 162 329 3 0 0
Totale 15.073